[go: up one dir, main page]

JP7554267B2 - 不安症などの治療における使用のための特定の比率の可溶性繊維と不溶性繊維を含む組成物 - Google Patents

不安症などの治療における使用のための特定の比率の可溶性繊維と不溶性繊維を含む組成物 Download PDF

Info

Publication number
JP7554267B2
JP7554267B2 JP2022536930A JP2022536930A JP7554267B2 JP 7554267 B2 JP7554267 B2 JP 7554267B2 JP 2022536930 A JP2022536930 A JP 2022536930A JP 2022536930 A JP2022536930 A JP 2022536930A JP 7554267 B2 JP7554267 B2 JP 7554267B2
Authority
JP
Japan
Prior art keywords
vitamin
fiber
insoluble
fatty acids
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2022536930A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023507372A (ja
Inventor
エフライム、エデン
ジュエル、デニス
Original Assignee
ヒルズ・ペット・ニュートリシャン・インコーポレーテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ヒルズ・ペット・ニュートリシャン・インコーポレーテッド filed Critical ヒルズ・ペット・ニュートリシャン・インコーポレーテッド
Publication of JP2023507372A publication Critical patent/JP2023507372A/ja
Application granted granted Critical
Publication of JP7554267B2 publication Critical patent/JP7554267B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/20Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K10/00Animal feeding-stuffs
    • A23K10/30Animal feeding-stuffs from material of plant origin, e.g. roots, seeds or hay; from material of fungal origin, e.g. mushrooms
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K20/00Accessory food factors for animal feeding-stuffs
    • A23K20/10Organic substances
    • A23K20/158Fatty acids; Fats; Products containing oils or fats
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K20/00Accessory food factors for animal feeding-stuffs
    • A23K20/10Organic substances
    • A23K20/174Vitamins
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K50/00Feeding-stuffs specially adapted for particular animals
    • A23K50/40Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/3533,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355Tocopherols, e.g. vitamin E
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365Lactones
    • A61K31/375Ascorbic acid, i.e. vitamin C; Salts thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716Glucans
    • A61K31/717Celluloses

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Food Science & Technology (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Animal Husbandry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Birds (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Physiology (AREA)
  • Fodder In General (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Feed For Specific Animals (AREA)
JP2022536930A 2019-12-19 2019-12-19 不安症などの治療における使用のための特定の比率の可溶性繊維と不溶性繊維を含む組成物 Active JP7554267B2 (ja)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2019/067568 WO2021126221A1 (en) 2019-12-19 2019-12-19 Compositions comprising a particular ratio of insoluble to soluble fibre for use in the treatment of e.g. anxiety

Publications (2)

Publication Number Publication Date
JP2023507372A JP2023507372A (ja) 2023-02-22
JP7554267B2 true JP7554267B2 (ja) 2024-09-19

Family

ID=69174627

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022536930A Active JP7554267B2 (ja) 2019-12-19 2019-12-19 不安症などの治療における使用のための特定の比率の可溶性繊維と不溶性繊維を含む組成物

Country Status (6)

Country Link
EP (1) EP4017276A1 (zh)
JP (1) JP7554267B2 (zh)
CN (1) CN114828643A (zh)
AU (1) AU2019479288B2 (zh)
CA (1) CA3164486A1 (zh)
WO (1) WO2021126221A1 (zh)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5419283A (en) 1992-04-08 1995-05-30 Ciuffo Gatto S.R.L. Animal chew toy of starch material and degradable ethylene copolymer
US5339771A (en) 1993-09-15 1994-08-23 Axelrod Herbert R Animal chew toy containing animal meal
US5776913A (en) 1995-10-10 1998-07-07 Colgate Palmolive Company Therapeutic diet for metabolic abnormalities found in animals with lymphoma
US6015798A (en) 1995-10-10 2000-01-18 Colgate Palmolive Company Method for reducing the damaging effects of radiation therapy on animal skin and mucosa
EP1981355B1 (en) * 2006-01-23 2018-03-14 Hill's Pet Nutrition, Inc. Methods for reducing food intake and controlling the weight of animals
AU2018453791B2 (en) * 2018-12-17 2022-07-14 Hill's Pet Nutrition, Inc. Pet food composition comprising insoluble fibers comprising lignin, polyphenol source, soluble fiber source

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
A BUROKAS; ET AL,TARGETING THE MICROBIOTA-GUT-BRAIN AXIS FOR STRESS-RELATED DISORDERS: PREBIOTICS 以下備考,EUROPEAN NEUROPSYCHOPHARMACOLOGY,2015年03月,VOL:25,PAGE(S):S44-S45,S(1),https://www.sciencedirect.com/journal/european-neuropsychopharmacology/vol/25/suppl/S1,SELECTIVELY REDUCE ANXIETY IN MICE
ANTHONY MARTIN; ET AL,GUT MICROBIOTA AND DIETARY FIBER MITIGATE AMINO ACID STRESS RESPONSE IN LOW-PROTEIN DIETS,CURRENT DEVELOPMENTS IN NUTRITION 2018,米国,2018年,VOL:2, NO:11,PAGE(S):NZY037(5),https://www.sciencedirect.com/science/article/pii/S2475299123120348/pdfft?md5=e3dac8cdab1c4dccae541a64f9e90e23&pid=1-s2.0-S2475299123120348-main.pdf
JASON SOARES; ET AL,IN VITRO EXPLORATION OF HEALTHY AND STRESSED GUT MICROBIOTA METABOLISM,CURRENT DEVELOPMENTS IN NUTRITION,OXFORD UNIVERSITY PRESS,2019年06月,VOL:3,PAGE(S):1760,https://www.sciencedirect.com/science/article/pii/S2475299123150979/pdfft?md5=3b49530af2f0070421cc40d5f7642928&pid=1-s2.0-S2475299123150979-main.pdf
MASSIMO MARZORATI; ET AL,HIGH-FIBER AND HIGH-PROTEIN DIETS SHAPE DIFFERENT GUT MICROBIAL COMMUNITIES, WHICH 以下備考,MOLECULAR NUTRITION & FOOD RESEARCH,2017年,VOL:61, NO:1,PAGE(S):1600150(1-13),https://onlinelibrary.wiley.com/doi/10.1002/mnfr.201600150,ECOLOGICALLY BEHAVE SIMILARLY UNDER STRESS CONDITIONS, AS SHOWN IN A GASTROINTESTINAL SIMULATOR
MATTEO M PUSCEDDU; ET AL,N-3 POLYUNSATURATED FATTY ACIDS (PUFAS) REVERSE THE IMPACT OF EARLY-LIFE STRESS ON 以下備考,PLOS ONE,2015年10月,PAGE(S):E0139721(1-13),https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0139721&type=printable,THE GUT MICROBIOTA

Also Published As

Publication number Publication date
CA3164486A1 (en) 2021-06-24
EP4017276A1 (en) 2022-06-29
CN114828643A (zh) 2022-07-29
WO2021126221A1 (en) 2021-06-24
AU2019479288A1 (en) 2022-06-30
JP2023507372A (ja) 2023-02-22
AU2019479288B2 (en) 2024-04-18

Similar Documents

Publication Publication Date Title
CA2890946C (en) Anti-aging foods for companion animals
US7744917B2 (en) Composition for animal consumption and method for reducing MAP kinase activity
CA2891920C (en) Anti-aging foods for companion animals
US11337958B2 (en) Compositions and methods of treating and reducing risk of conditions associated with elevated 4-ethylphenyl sulfate
JP7554267B2 (ja) 不安症などの治療における使用のための特定の比率の可溶性繊維と不溶性繊維を含む組成物
JP7542065B2 (ja) 上昇した4-エチルフェニル硫酸と関連付けられた状態の治療およびリスクを低減する組成物および方法
US11439616B2 (en) Compositions and methods of treating and reducing risk of conditions associated with elevated 4-ethylphenyl sulfate
JP6001184B2 (ja) 食餌のミネラル制限を介したヘアボール制御

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20220616

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20220616

RD03 Notification of appointment of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7423

Effective date: 20230213

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20230606

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20230906

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20231020

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20240116

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20240516

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20240523

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20240820

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20240906

R150 Certificate of patent or registration of utility model

Ref document number: 7554267

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150